Patents-Review.com
ClassID:

20468 ⎘

A61K31/565 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Recent Application in this class:
#301
20210169898
2021-06-10

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

 #302
20210169897
2021-06-10

Concentrated Fulvestrant Compositions

 #303
20210163399
2021-06-03

NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME

 #304
20210161991
2021-06-03

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

 #305
20210154212
2021-05-27

Compounds and their uses for alleviating menopause-associated symptoms

 #306
20210154211
2021-05-27

Compounds and their uses for alleviating menopause-associated symptoms

 #307
20210154206
2021-05-27

WOUND HEALING MEDICAMENT

 #308
20210147129
2021-05-20

Anti-scalping pharmaceutical packaging film

 #309
20210145895
2021-05-20

Immunoisolation device

 #310
20210145846
2021-05-20

HIGH-CONCENTRATION FULVESTRANT COMPOSITIONS

 #311
20210137943
2021-05-13

ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS

 #312
20210128672
2021-05-06

Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics

 #313
20210121502
2021-04-29

USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI

 #314
20210121480
2021-04-29

STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRADIOL AND PROGESTERONE FOR ORAL ADMINISTRATION

 #315
20210113589
2021-04-22

Targeting NCchannel for organ protection following ischemic episode

 #316
20210102208
2021-04-08

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

 #317
20210085700
2021-03-25

TARGETED THERAPEUTICS

 #318
20210077516
2021-03-18

Vaginal composition and use thereof

 #319
20210077436
2021-03-18

Method of treating or preventing neurodegeneration

 #320
20210069210
2021-03-11

Vaginal composition comprising a combination of estrogen and vitamin D

 #321
20210052526
2021-02-25

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

 #322
20210046085
2021-02-18

TREATMENT OF ADVANCED ESTROGEN RECEPTOR POSITIVE BREAST CANCER

 #323
20210046084
2021-02-18

TREATMENT OF ADVANCED ESTROGEN RECEPTOR POSITIVE BREAST CANCER

 #324
20210038617
2021-02-11

USE OF ANDROGENS FOR TREATING VARIOUS DISEASES

 #325
20210023093
2021-01-28

Transdermal Delivery

 #326
20210023092
2021-01-28

Transdermal Delivery

 #327
20210015826
2021-01-21

ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

 #328
20210007976
2021-01-14

Segmented EVA Intravaginal Rings

 #329
20210000741
2021-01-07

Pharmaceutical compositions comprising silica microspheres

 #330
20200405809
2020-12-31

COMBINATION OF A CYCLIN DEPENDENT KINASE INHIBITOR AND A BET- BROMODOMAIN INHIBITOR

 #331
20200397692
2020-12-24

System for providing birth control

 #332
20200390710
2020-12-17

Method for the Production of Commercial Nanoparticle and Microparticle Powders

 #333
20200390695
2020-12-17

TIME-RELEASE AND MICRO-DOSE FORMULATIONS FOR TOPICAL APPLICATION OF ESTROGEN AND ESTROGEN ANALOGS OR OTHER ESTROGEN RECEPTOR MODULATORS IN THE TREATMENT OF DRY EYE SYNDROME, AND METHODS OF PREPARATION AND APPLICATION

 #334
20200376132
2020-12-03

Hyaluronan conjugates and uses thereof

 #335
20200376005
2020-12-03

SHIP INHIBITION TO COMBAT OBESITY

 #336
20200376002
2020-12-03

Injectable Hormone Formulations for Estrous Cycle Control in Mammals, its Manufacturing Process, Estrous Cycle Control and Puberty Triggering Methods, and Pregnancy Enhancement in Mammals

 #337
20200369728
2020-11-26

PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF

 #338
20200368184
2020-11-26

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #339
20200368147
2020-11-26

METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS

 #340
20200352962
2020-11-12

Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies

 #341
20200352961
2020-11-12

Soluble estradiol capsule for vaginal insertion

 #342
20200352960
2020-11-12

Steroidal hormones for the treatment and prevention of wave burst arrhythmia

 #343
20200352959
2020-11-12

Orodispersible dosage unit containing an estetrol component

 #344
20200352850
2020-11-12

METHOD FOR MANUFACTURING PREPARATION FOR INJECTION

 #345
20200345783
2020-11-05

COMPOSITION USED FOR THERAPEUTIC TREATMENT OF SKIN DISEASE

 #346
20200345751
2020-11-05

Fulvestrant compositions and method of use

 #347
20200345736
2020-11-05

4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors

 #348
20200345582
2020-11-05

Adapter for a dispensing container in a planetary mixer

 #349
20200345581
2020-11-05

Adaptor for a dispensing container in a planetary mixer

 #350
20200338091
2020-10-29

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

 #351
20200323881
2020-10-15

SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION

 #352
20200317718
2020-10-08

Therapeutically active steroidal derivatives

 #353
20200316090
2020-10-08

TARGETED THERAPEUTICS

 #354
20200306261
2020-10-01

Compounds, compositions and methods for prevention and/or treatment of cancer

 #355
20200306228
2020-10-01

Secnidazole for use in the treatment of trichomoniasis

 #356
20200297848
2020-09-24

METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM

 #357
20200297736
2020-09-24

Vaginal inserted estradiol pharmaceutical compositions and methods

 #358
20200297735
2020-09-24

Vaginal inserted estradiol pharmaceutical compositions and methods

 #359
20200297691
2020-09-24

Compounds and forms of treatment for female sexual disorders

 #360
20200291060
2020-09-17

7-dehydrocholesterol derivatives and methods using same

 #361
20200289529
2020-09-17

Soluble estradiol capsule for vaginal insertion

 #362
20200289470
2020-09-17

Secnidazole for use in the treatment of trichomoniasis

 #363
20200281941
2020-09-10

Natural combination hormone replacement formulations and therapies

 #364
20200281940
2020-09-10

Natural combination hormone replacement formulations and therapies

 #365
20200281938
2020-09-10

Natural combination hormone replacement formulations and therapies

 #366
20200281849
2020-09-10

Vaginal inserted estradiol pharmaceutical compositions and methods

 #367
20200276210
2020-09-03

SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION

 #368
20200268752
2020-08-27

METHODS OF ADMINISTERING ELAGOLIX

 #369
20200253912
2020-08-13

Modulators of prostate-specific g-protein receptor (PSGR/OR51E2) and methods of using same

 #370
20200246354
2020-08-06

Adjuvant therapy for use in prostate cancer treatment

 #371
20200246258
2020-08-06

METHOD OF PROVIDING BIRTH CONTROL

 #372
20200246257
2020-08-06

Method of providing birth control

 #373
20200246256
2020-08-06

Method of providing birth control

 #374
20200237670
2020-07-30

DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE

 #375
20200230154
2020-07-23

Soluble estradiol capsule for vaginal insertion

 #376
20200230153
2020-07-23

Soluble estradiol capsule for vaginal insertion

 #377
20200230050
2020-07-23

Vaginal inserted estradiol pharmaceutical compositions and methods

 #378
20200215150
2020-07-09

Medicine for combined use in cancer treatment

 #379
20200206242
2020-07-02

Vaginal inserted estradiol pharmaceutical compositions and methods

 #380
20200206192
2020-07-02

Secnidazole for use in the treatment of bacterial vaginosis

 #381
20200206167
2020-07-02

INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION

 #382
20200197410
2020-06-25

D2O stabilized pharmaceutical formulations

 #383
20200188411
2020-06-18

FULVESTRANT FORMULATIONS

 #384
20200179390
2020-06-11

Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss

 #385
20200179274
2020-06-11

DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF

 #386
20200171050
2020-06-04

Soluble estradiol capsule for vaginal insertion

 #387
20200171048
2020-06-04

PREVENTION OF BOAR TAINT AND AGGRESSION

 #388
20200171047
2020-06-04

Cat and dog sterilization by estrogenic compounds

 #389
20200171032
2020-06-04

METHODS AND MEDICAL USES

 #390
20200163965
2020-05-28

Methods of treating heavy menstrual bleeding

 #391
20200163902
2020-05-28

THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF

 #392
20200155465
2020-05-21

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

 #393
20200147167
2020-05-14

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

 #394
20200147105
2020-05-14

Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen

 #395
20200147104
2020-05-14

Vaginal inserted estradiol pharmaceutical compositions and methods

 #396
20200138832
2020-05-07

COMPOUNDS AND PRODRUGS THEREOF FOR THE TREATMENT OF OPHTHALMIC DISEASE

 #397
20200138824
2020-05-07

TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESELECTED FOR HAVING A PIK3CA MUTATION IN THE CTDNA

 #398
20200138820
2020-05-07

ORGANIC COMPOUNDS

 #399
20200129743
2020-04-30

Applicator and system for administering and dispensing flowable pharmaceutical preparations

 #400
20200129583
2020-04-30

COMPOSITION FOR TREATING ACUTE URINARY RETENTION

 #401
20200129524
2020-04-30

PERSONALIZED CONTRACEPTIVE FORMULATIONS

 #402
20200129523
2020-04-30

SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT

 #403
20200123271
2020-04-23

COMPOSITION FOR ENHANCING SENSITIVITY OF PROSTATE CANCER TO ANTICANCER DRUG AND USE THEREOF

 #404
20200121680
2020-04-23

Methods of administering elagolix

 #405
20200121621
2020-04-23

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #406
20200121589
2020-04-23

COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE THEREOF

 #407
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #408
20200101085
2020-04-02

TRANSPORE DELIVERY OF DRUGS AND USES THEREOF

 #409
20200101055
2020-04-02

CYP2J2 antagonists in the treatment of pain

 #410
20200085841
2020-03-19

Applications for estradiol in preparing anti-small cell lung cancer and/or ovarian cancer and/or osteosarcoma products

 #411
20200071279
2020-03-05

DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF

 #412
20200069700
2020-03-05

Vaginal inserted estradiol pharmaceutical compositions and methods

 #413
20200061083
2020-02-27

Methods for inhibiting muscle atrophy

 #414
20200061082
2020-02-27

FORMULATIONS AND METHODS FOR PROVIDING PROGESTIN-ONLY CONTRACEPTION WHILE MINIMIZING ADVERSE SIDE EFFECTS ASSOCIATED THEREWITH

 #415
20200061081
2020-02-27

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

 #416
20200061080
2020-02-27

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

 #417
20200054522
2020-02-20

Adapter for use in a planetary mixer

 #418
20200046734
2020-02-13

Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk

 #419
20200046729
2020-02-13

METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS

 #420
20200038372
2020-02-06

Secnidazole for use in the treatment of bacterial vaginosis

 #421
20200022958
2020-01-23

Secnidazole for use in the treatment of bacterial vaginosis

 #422
20200017542
2020-01-16

Neuroactive steroids, compositions, and uses thereof

 #423
20200009084
2020-01-09

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #424
20200009073
2020-01-09

Fibre-free transdermal therapeutic system and method for its production

 #425
20190388497
2019-12-26

Immunorhelin compounds for intracellular infections

 #426
20190388349
2019-12-26

NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO

 #427
20190374590
2019-12-12

USE OF CORDYCEPS MILITARIS EXTRACT FOR TREATMENT OF RENAL DISEASE

 #428
20190365902
2019-12-05

Vaginal hydrogel

 #429
20190358243
2019-11-28

Vaginal inserted estradiol pharmaceutical compositions and methods

 #430
20190344060
2019-11-14

Adjustable rate drug delivery implantable device

 #431
20190343856
2019-11-14

Compositions for the treatment of skin conditions

 #432
20190343845
2019-11-14

Natural combination hormone replacement formulations and therapies

 #433
20190343771
2019-11-14

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

 #434
20190328659
2019-10-31

ELASTIC SHEET WITH FUNCTION OF RE-ACTIVATING ENDOMETRIAL BASAL LAYER IN UTERINE CAVITY AND FORMING METHOD THEREOF

 #435
20190328658
2019-10-31

ESTROGEN PRODRUGS AND METHODS OF ADMINISTERING ESTROGEN PRODRUGS

 #436
20190328657
2019-10-31

HORMONAL CONTRACEPTION USING A VAGINAL RING WHICH RELEASES ESTRIOL

 #437
20190328656
2019-10-31

TARGETED DELIVERY OF PROGESTINS AND ESTROGENS VIA VAGINAL RING DEVICES FOR FERTILITY CONTROL AND HRT PRODUCTS

 #438
20190321491
2019-10-24

Nanocarriers for prostate cancer cell targeted therapy and/or diagnosis thereof

 #439
20190321376
2019-10-24

Formulations for solubilizing hormones

 #440
20190314386
2019-10-17

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

 #441
20190307774
2019-10-10

Composition and method to aid in hormone replacement therapy

 #442
20190307771
2019-10-10

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES

 #443
20190307770
2019-10-10

METHODS FOR TREATING OR PREVENTING CANCER IN A KRAS-VARIANT PATIENT AND FOR DIAGNOSING RISK OF DEVELOPING MULTIPLE PRIMARY BREAST TUMORS

 #444
20190282587
2019-09-19

Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen

 #445
20190282541
2019-09-19

USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER

 #446
20190269695
2019-09-05

COMPOSITIONS COMPRISING 5-CHOLESTEN-3, 25-DIOL, 3-SULFATE (25HC3S) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AT LEAST ONE CYCLIC OLIGOSACCHARIDE

 #447
20190269611
2019-09-05

In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases

 #448
20190262346
2019-08-29

Methods of treating uterine fibroids

 #449
20190255140
2019-08-22

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

 #450
20190255020
2019-08-22

Secnidazole for use in the treatment of bacterial vaginosis

 #451
20190247306
2019-08-15

ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS

 #452
20190240190
2019-08-08

Non-hormonal treatment of the genitourinary syndrome of menopause

 #453
20190240149
2019-08-08

Pharmaceutical compositions comprising silica microspheres

 #454
20190233897
2019-08-01

NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF

 #455
20190224213
2019-07-25

VAGINAL COMPOSITION COMPRISING A COMBINATION OF ESTROGEN AND VITAMIN D

 #456
20190224073
2019-07-25

Pharmaceutical compounding methods and systems

 #457
20190216726
2019-07-18

Particles, Compositions and Methods for Ophthalmic and/or Other Applications

 #458
20190209680
2019-07-11

TREATMENT OF ACUTE LIVER FAILURE

 #459
20190209563
2019-07-11

Methods of treating heavy menstrual bleeding

 #460
20190209562
2019-07-11

METHODS OF TREATING HEAVY MENSTRUAL BLEEDING

 #461
20190184145
2019-06-20

Implants for localized drug delivery and methods of use thereof

 #462
20190175614
2019-06-13

Estrogen receptor modulator combinations

 #463
20190175611
2019-06-13

Remyelination Therapy

 #464
20190160078
2019-05-30

GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS

 #465
20190160077
2019-05-30

Transdermal pharmaceutical compositions comprising active agents

 #466
20190160020
2019-05-30

Transdermal packaging membranes

 #467
20190151333
2019-05-23

Fulvestrant formulations

 #468
20190142844
2019-05-16

Natural combination hormone replacement formulations and therapies

 #469
20190134059
2019-05-09

FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE

 #470
20190125759
2019-05-02

Orodispersible dosage unit containing an estetrol component

 #471
20190125687
2019-05-02

Microcapsules for controlled delivery of an active pharmaceutical ingredient

 #472
20190117672
2019-04-25

Targeting NCchannel for organ protection following ischemic episode

 #473
20190111063
2019-04-18

Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith

 #474
20190105333
2019-04-11

Methods for inhibiting muscle atrophy

 #475
20190099432
2019-04-04

Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith

 #476
20190093182
2019-03-28

Method of quantifying HIV reservoirs by induced transcription based sequencing

 #477
20190091330
2019-03-28

Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites

 #478
20190091227
2019-03-28

METHODS FOR TREATING ER+, HER2-, HRG+ BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ANTI-ERBB3 ANTIBODY

 #479
20190091141
2019-03-28

Geometrically complex intravaginal rings, systems and methods of making the same

 #480
20190083421
2019-03-21

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

 #481
20190070197
2019-03-07

TRANSDERMAL CREAM

 #482
20190070195
2019-03-07

Pharmaceutical composition

 #483
20190054093
2019-02-21

TREATMENT OF SARCOPENIA WITH ECDYSTEROIDS

 #484
20190046542
2019-02-14

Natural combination hormone replacement formulations and therapies

 #485
20190046533
2019-02-14

Combination therapy for the treatment of cancer

 #486
20190038661
2019-02-07

Rapid release pharmaceutical formulations containing algal cellulose

 #487
20190038591
2019-02-07

Use of a fasting mimicking diet to enhance the efficacy of antiestrogens in cancer

 #488
20190030161
2019-01-31

BREAST CANCER THERAPEUTICS

 #489
20190022109
2019-01-24

Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen

 #490
20190022108
2019-01-24

Pharmaceutical composition

 #491
20190022107
2019-01-24

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

 #492
20190008968
2019-01-10

Progesterone formulations

 #493
20190008797
2019-01-10

ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF

 #494
20190008760
2019-01-10

Methods of treating eosinophilic esophagitis

 #495
20190008723
2019-01-10

Container assembly

 #496
20190000927
2019-01-03

Treatment of disease with relaxin

 #497
20180360848
2018-12-20

Pharmaceutical compositions containing testosterone and an aromatase inhibitor

 #498
20180360847
2018-12-20

Pharmaceutical compositions for radioprotection or radiomitigation and methods for using them

 #499
20180354984
2018-12-13

Therapeutically active steroidal derivatives

 #500
20180353515
2018-12-13

TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESSELECTED FOR HAVING A PIK3CA MUTATION IN THE CTDNA

 #501
20180333391
2018-11-22

Secnidazole for use in the treatment of bacterial vaginosis

 #502
20180320238
2018-11-08

Estrogen receptor mutations and uses thereof

 #503
20180318360
2018-11-08

Immunoisolation device

 #504
20180317459
2018-11-08

Method for producing YY super-male and XY physiological female common carps

 #505
20180296500
2018-10-18

Treatment of prostate carcinoma

 #506
20180289937
2018-10-11

APPLICATOR AND SYSTEM FOR ADMINISTERING AND DISPENSING FLOWABLE PHARMACEUTICAL PREPARATIONS

 #507
20180289723
2018-10-11

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS

 #508
20180289722
2018-10-11

Fulvestrant formulations

 #509
20180289721
2018-10-11

FULVESTRANT COMPOSITIONS

 #510
20180289614
2018-10-11

Formulations and methods for controlling the reproductive cycle and ovulation

 #511
20180280411
2018-10-04

Steroid hormone pharmaceutical composition

 #512
20180280408
2018-10-04

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

 #513
20180273580
2018-09-27

7-dehydrocholesterol derivatives and methods using same

 #514
20180263901
2018-09-20

Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application

 #515
20180263899
2018-09-20

Intrauterine delivery system for contraception

 #516
20180256598
2018-09-13

Vaginal inserted estradiol pharmaceutical compositions and methods

 #517
20180256513
2018-09-13

Method for the treatment or prevention of lower urinary tract symptoms

 #518
20180250366
2018-09-06

Compositions and methods for protecting the kidney from ischemia reperfusion injury

 #519
20180243125
2018-08-30

Vaginal ring applicator

 #520
20180235963
2018-08-23

Methods of administering elagolix

 #521
20180235951
2018-08-23

Use of ceranib-2 in the treatment of lung cancer

 #522
20180235945
2018-08-23

Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof

 #523
20180221389
2018-08-09

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

 #524
20180221301
2018-08-09

TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY

 #525
20180215779
2018-08-02

Neuroactive steroids, compositions, and uses thereof

 #526
20180211566
2018-07-26

Skin punch biopsy and wound-debridgement training model

 #527
20180207097
2018-07-26

NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO

 #528
20180185504
2018-07-05

Methods of treating PRLR positive breast cancer

 #529
20180185451
2018-07-05

Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug

 #530
20180185386
2018-07-05

APPLICATIONS FOR ESTRADIOL IN PREPARING ANTI-SMALL CELL LUNG CANCER AND/OR OVARIAN CANCER AND/OR OSTEOSARCOMA PRODUCTS

 #531
20180185271
2018-07-05

Orodispersible tablet containing Estetrol

 #532
20180177841
2018-06-28

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

 #533
20180169022
2018-06-21

Orodispersible dosage unit containing an estetrol component

 #534
20180161346
2018-06-14

Diarylpropionitrile therapy for treatment of multiple sclerosis

 #535
20180161345
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

 #536
20180161344
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

 #537
20180161343
2018-06-14

Vaginal inserted estradiol pharmaceutical compositions and methods

 #538
20180153909
2018-06-07

Combination therapy for skin disorders

 #539
20180153868
2018-06-07

TREATMENT OF BREAST CANCER BY CONCOMITANT ADMINISTRATION OF A BROMODOMAIN INHIBITOR AND A SECOND AGENT

 #540
20180153801
2018-06-07

Orodispersible tablet containing estetrol

 #541
20180147214
2018-05-31

DO stabilized pharmaceutical formulations

 #542
20180133145
2018-05-17

Methods of treating eosinophilic esophagitis

 #543
20180125860
2018-05-10

Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects

 #544
20180125859
2018-05-10

Methods for Inhibiting the Development of Huntington's Disease

 #545
20180125753
2018-05-10

Pharmaceutical compounding methods and systems

 #546
20180117063
2018-05-03

Orally disintegrating solid dosage unit containing an estetrol component

 #547
20180116992
2018-05-03

Modulators of prostate-specific G-protein receptor (PSGR/OR51E2) and methods of using same

 #548
20180116977
2018-05-03

NOVEL TREATMENT OF PROSTATE CARCINOMA

 #549
20180104259
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

 #550
20180104258
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

 #551
20180104256
2018-04-19

TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY

 #552
20180104181
2018-04-19

Long acting drug delivery device and its use in contraception

 #553
20180085379
2018-03-29

Methods of monitoring estriol therapy

 #554
20180078493
2018-03-22

TRANSDERMAL HORMONE DELIVERY

 #555
20180071391
2018-03-15

Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine

 #556
20180071390
2018-03-15

Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives

 #557
20180071316
2018-03-15

Compositions and methods for treating dementia

 #558
20180071313
2018-03-15

DRY EYE THERAPEUTIC AGENT COMPRISING NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF AS AN ACTIVE INGREDIENT

 #559
20180071310
2018-03-15

COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS

 #560
20180071309
2018-03-15

Fulvestrant compositions and method of use

 #561
20180066065
2018-03-08

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

 #562
20180065904
2018-03-08

Introduction of alkyl substituents to aromatic compounds

 #563
20180057813
2018-03-01

Compositions and methods for nucleic acid transfer

 #564
20180055896
2018-03-01

COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN

 #565
20180050046
2018-02-22

Fulvestrant formulations

 #566
20180049999
2018-02-22

COMPOSITIONS AND METHODS OF TREATMENT OF BREAST DISORDERS AND ESTROGEN-RELATED DISORDERS

 #567
20180049997
2018-02-22

Cholesteryl ester transfer protein (CETP) inhibition in the treatment of cancer

 #568
20180044341
2018-02-15

4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments

 #569
20180042986
2018-02-15

Chemical Induction of Lactation in Prepubescent Non-Human Mammals

 #570
20180036522
2018-02-08

Adjustable rate drug delivery implantable device

 #571
20180036395
2018-02-08

DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1R AND ANTI-ERBB3 ANTIBODIES

 #572
20180036252
2018-02-08

Pharmaceutical soft gelatin capsule dosage form with modified guar gum

 #573
20180036226
2018-02-08

Transmucosal and transdermal delivery systems

 #574
20180021259
2018-01-25

DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE

 #575
20180015127
2018-01-18

Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells

 #576
20180015102
2018-01-18

Oral transmucosal drug delivery system

 #577
20180008534
2018-01-11

METHOD FOR PREVENTING, TREATING, AND CURING CANCER

 #578
20180002583
2018-01-04

Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same

 #579
20170360803
2017-12-21

Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing risk of developing multiple primary breast tumors

 #580
20170360725
2017-12-21

FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

 #581
20170348325
2017-12-07

Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies

 #582
20170348322
2017-12-07

BK Channels as Non-Genomic Estrogen Targets for Overactive Bladder

 #583
20170340660
2017-11-30

Non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing same as active ingredient

 #584
20170340602
2017-11-30

Compounds and forms of treatment for Female Sexual Disorders

 #585
20170333688
2017-11-23

DISPESNING DEVICES FOR TOPICAL PHARMACEUCTAL COMPOSITIONS

 #586
20170333447
2017-11-23

HORMONE DELIVERY SYSTEM AND METHOD

 #587
20170333446
2017-11-23

COMPOUNDED FORMULA FOR MENOPAUSE RELIEF

 #588
20170326155
2017-11-16

NOVEL PHARMACOLOGICAL THERAPY FOR NEUROMUSCULAR CONTRACTURES

 #589
20170319597
2017-11-09

Methods of reducing mammographic breast density and/or breast cancer risk

 #590
20170312219
2017-11-02

METHOD OF CONTRACEPTION

 #591
20170304392
2017-10-26

Dab2 inhibitors for the prevention and treatment of cystic fibrosis

 #592
20170296555
2017-10-19

Targeting NCchannel for organ protection following ischemic episode

 #593
20170290845
2017-10-12

Estrogen therapy for brain gray matter atrophy and associated disability

 #594
20170281652
2017-10-05

Therapeutic Compositions and Methods

 #595
20170281647
2017-10-05

STEROID HORMONE COMPOSITIONS IN MEDIUM CHAIN OILS

 #596
20170281646
2017-10-05

STEROID HORMONE PHARMACEUTICAL COMPOSITION

 #597
20170281637
2017-10-05

Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors

 #598
20170274077
2017-09-28

Methods for increasing red blood cell levels and treating ineffective erythropoiesis

 #599
20170269088
2017-09-21

Targeting breast cancer therapy based on stromal subtypes and CD146 composition

 #600
20170266203
2017-09-21

Fulvestrant compositions and method of use